GRAL

GRAIL INC

GRAL·384747101·US·Common Stock·Healthcare - Diagnostics & Research-13D/G

GRAL (GRAIL INC) is held by 155 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($208.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($168.2M), BlackRock, Inc. ($153.4M). Net institutional sentiment: Mixed.

155
Holders
(35 Elite)
$1.5B
Total Value
48% (158)
Consensus
76 buying - 82 selling
13F: Insider & Congress:
GRALSmart Money Verdict
View all
Held by 155 funds
35 elite
Who's Trading
ActivistBaker Bros. Advisors LPBaker Bros. Advisors LP9.8%May 15, 2026
ActivistDJDapice Joshua J.7.8%May 11, 2026
InsiderRPRAGUSA ROBERT PSell $6.2MApr 8, 2026
InsiderOJOfman Joshua J.Sell $3.1MApr 8, 2026
InsiderFAFreidin AaronSell $2.3MApr 8, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderRPRAGUSA ROBERT PSell $345KMar 9, 2026
InsiderRPRAGUSA ROBERT PSell $12KMar 9, 2026
InsiderOJOfman Joshua J.Sell $136KMar 9, 2026
InsiderOJOfman Joshua J.Sell $5KMar 9, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4M(+93.2%)$208.2M1.2%+68.89%
76
Increased
3.3M(+38.9%)$168.2M1.0%+13.23%
57
Increased
3M(+0.3%)$153.4M0.0%+74.21%
30
Increased
1.9M(+3.5%)$97.8M0.0%+84.20%
31
Increased
1.8M(+0.3%)$95.3M0.1%+368.25%
30
Increased
1.6M(+8.0%)$84.4M0.0%+27.17%
32
New
1.5M$78.9M0.0%+36.47%
41
Increased
914,114(+29.0%)$47.2M0.0%+14.41%
37
Increased
827,942(+3.3%)$42.8M0.0%+111.71%
30
New
657,500$34M0.2%+36.47%
48
Increased
645,456(+45.9%)$33.4M0.1%-4.09%
39
Increased
581,924(+8.4%)$30.1M0.0%+13.34%
31
Unchanged
428,266$22.1M0.2%-15.59%
0
Increased
408,650(+88.5%)$21.1M0.0%+16.05%
45
Increased
349,137(+2.3%)$18M0.0%+109.79%
29
New
334,906$17.3M0.0%+36.47%
39
Increased
304,808(+1564.9%)$15.8M0.0%+34.98%
45
Increased
302,136(+347.4%)$15.6M0.0%+44.39%
45
Increased
292,138(+12.9%)$15.1M0.0%+38.18%
32
Decreased
292,004(-10.7%)$14.6M0.0%+255.55%
0

Showing 1-20 of 176

1 / 9

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used